SFS
AXSM icon

Sowell Financial Services’s Axsome Therapeutics AXSM Stock Holding History

Sowell Financial Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-368
Closed -$21K – 711
2021
Q1 		$21K Buy
368
+12
+3% +$844 ﹤0.01% 2042
2020
Q4 		$29K Sell
356
-19
-5% -$1.42K ﹤0.01% 1589
2020
Q3 		$27K Sell
375
-46
-11% -$3.58K ﹤0.01% 1424
2020
Q2 		$35K Sell
421
-423
-50% -$32.6K ﹤0.01% 1280
2020
Q1 		$50K Sell
844
-805
-49% -$65.6K ﹤0.01% 1058
2019
Q4 		$170K Buy
1,649
+909
+123% +$36.7K 0.01% 766
2019
Q3 		$15K Buy
+740
New +$19K ﹤0.01% 1379

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Sowell Financial Services's AXSM Position: Q2 2021 in Review

Sowell Financial Services sold out of Axsome Therapeutics (AXSM) in Q2 2021, closing a stake of 368 shares — an estimated $21K sold.

Sowell Financial Services first reported a position in AXSM in Q3 2019 and held it in 7 quarters. The position peaked at $170K in Q4 2019. 176 funds tracked by Wall St. Rank hold AXSM as of Q2 2021.

  • Sowell Financial Services reported no remaining Axsome Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 368 Axsome Therapeutics shares in Q2 2021, an estimated $21K.
  • Sowell Financial Services first reported a position in Axsome Therapeutics in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Axsome Therapeutics position peaked at $170K in Q4 2019.
  • 176 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.